Kenneth Hoberman, Chief Operating Officer at STEMLINE THERAPEUTICS INC (STML), sold 42,895 shares at $4.91 ($212K) on 2020-03-10, disclosed to the SEC on 2020-03-13.
Seasonal sale ($212k) by Chief Operating Officer — this insider has traded STML in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.08 | 9,487 | $48K | 22.7% |
| 2 | $4.91 | 16,704 | $82K | 38.6% |
| 3 | $4.91 | 16,704 | $82K | 38.6% |
| Total | $4.95 avg | 42,895 | $212K | 100% |
| Filing → |
| STML | SELL | 2020-01-24 | $311K | — | Filing → |
| STML | SELL | 2020-01-10 | $274K | — | Filing → |
| STML | SELL | 2020-01-03 | $937K | — | Filing → |